FundedIQ
Biotechnology

Imbed Biosciences: Funding, Investors & Team (Oct 2026)

Imbed Biosciences, Inc is a privately owned medical device company that is working on developing innovative technologies for incorporating bioactive substances into wound dressings and surgical implants. Through its unique biomaterials platforms, Imbed is transforming wound dressings to prevent infections and speed up wound healing. Ultimately, this could help reduce the overall cost of managing surgical and chronic wounds, which represents a $3 billion market opportunity in the U.S. and Europe. Imbed was created as a spin-off from the University of Wisconsin-Madison, building on four years of research conducted by a team of engineers, veterinary scientists, and medical surgeons. Together, the founders have more than 25 years of experience in clinical wound management.

www.imbedbio.com LinkedIn Fitchburg, United States 11-50 employees
Total raised
$10.8M
Rounds
3
Latest
Undisclosed round
Jan 2026

Imbed Biosciences has raised $10.8M across 3 funding rounds on record, the most recent an undisclosed round announced in Jan 2026.

Imbed Biosciences Company Profile and Key Stats

Total funding raised
$10.8M
across 3 rounds on record
Funding rounds on record
3
1 with no disclosed amount
Latest funding round
Undisclosed round
Jan 2026
Employees
11-50
reported band
Headquarters
Fitchburg, United States

Latest funding round on record: Jan 2026.

Imbed Biosciences Funding Rounds

Date
Round
Amount
Undisclosed round
Undisclosed
Undisclosed round
$10.0M
Grant
$800k

1 of 3 rounds was announced without a disclosed amount and is excluded from the total.

Imbed Biosciences raised $800k in a Grant announced in Oct 2021.

2.3 years later, an undisclosed round of $10.0M was announced in Jan 2024.

2 years later, an undisclosed round was announced in Jan 2026 with no disclosed amount.

Imbed Biosciences Founders and Leadership Team

Name
Role
Contact
Ankit Agarwal
Founder
Locked
Nicholas Abbott
Founder
—

Contact details for the Imbed Biosciences team: 1 of 2 have an email address on file.

Start 14-day free trial →

Imbed Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,148
$7.5M

Funded Startups Like Imbed Biosciences in Biotechnology and Fitchburg

Companies Similar to Imbed Biosciences

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…

Private Equity —

Imbed Biosciences Funding FAQs

What does Imbed Biosciences do?

Imbed Biosciences, Inc is a privately owned medical device company that is working on developing innovative technologies for incorporating bioactive substances into wound dressings and surgical implants. Through its unique biomaterials platforms, Imbed is transforming wound dressings to prevent infections and speed up wound healing. Ultimately, this could help reduce the overall cost of managing surgical and chronic wounds, which represents a $3 billion market opportunity in the U.S. and Europe. Imbed was created as a spin-off from the University of Wisconsin-Madison, building on four years of research conducted by a team of engineers, veterinary scientists, and medical surgeons. Together, the founders have more than 25 years of experience in clinical wound management.

How much funding has Imbed Biosciences raised?

Imbed Biosciences has raised $10.8M across 3 rounds on record.

When did Imbed Biosciences last raise funding?

Imbed Biosciences' most recent funding round on record was announced in Jan 2026. The amount was not disclosed.

Who founded Imbed Biosciences?

FundedIQ lists Ankit Agarwal (Founder), Nicholas Abbott (Founder) at Imbed Biosciences.

Where is Imbed Biosciences headquartered?

Imbed Biosciences is based in Fitchburg, Wisconsin, United States.

How many employees does Imbed Biosciences have?

Imbed Biosciences is in the 11-50 employee band.

About FundedIQ's Imbed Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Imbed Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.